The distribution of halothane-82 Br in maternal and foetal tissues was studied in nearterm pregnant guineapigs exposed to 0.5% concentration of the vapour for periods varying from 5 to 45 min. At all times observed, the specific activity of the 82 Br label was higher in maternal brain, lung and kidney than in the corresponding foetal tissues. In contrast, specific activity was slightly higher in foetal than in maternal liver up to 20 min and more than three times greater at 30 and at 45 min. The uptake of halothane by foetal liver in vitro was more than double that of maternal liver; in maternal and foetal brain the uptake was identical. The foetal liver plays a significant role in decreasing the amount of halothane reaching the foetal brain from the maternal circulation.
Br label was higher in maternal brain, lung and kidney than in the corresponding foetal tissues. In contrast, specific activity was slightly higher in foetal than in maternal liver up to 20 min and more than three times greater at 30 and at 45 min. The uptake of halothane by foetal liver in vitro was more than double that of maternal liver; in maternal and foetal brain the uptake was identical. The foetal liver plays a significant role in decreasing the amount of halothane reaching the foetal brain from the maternal circulation.
Halothane has been demonstrated in humans to pass rapidly from the maternal to the foetal circulation (Sheridan and Robson, 1959) . Other inhaled anaesthetics, namely diethyl ether (Smith and Barker, 1942) , cyclopropane (Apgar, Holaday and James, 1957) , nitrous oxide (Smith, 1940; Cohen et al., 1953; Marx, Joshi and Orkin, 1970) and methoxyflurane (Siker et al., 1968) have been shown to cross the placenta with ease, appearing in significant concentrations in umbilical cord blood. However, the distribution of none of these agents has been studied in foetal tissues and the placenta.
The purpose of our investigation was to determine the time course of the placental transfer of 82 Br labelled halothane in guineapigs and the subsequent distribution of this anaesthetic in both foetal and maternal tissues. Estimation of free 82 Br from the labelled halothane allowed determination of metabolism of halothane in individual tissues. Halothane labelled with 82 Br was chosen in preference to relabelled halothane because of its superior properties when used in kinetic and metabolic studies. The high energy gamma radiation of 82 Br allowed rapid quantitation of halothane in tissue samples by external scintillation detectors. Halothane labelled with weak beta-emitting 14 C would have required either liquid scintillation counting or prolonged exposure to photographic film for its detection.
MATERIAL AND METHODS
The preparation of halothane-8 2 Br has been reported by Geddes (1966) . In the present study, the medical reactor at Brookhaven National Laboratory was utilized for 82 Br-labelling by neutron activation of commercial halothane encapsulated in a silica ampoule. Following removal of free 82 Br with sodium thiosulphate, the halothane-82 Br was purified by preparative gas chromatography until it contained less than 25 p.p.m. of impurities.
Seventeen pregnant guineapigs at or near term were exposed in a 40-1. glass chamber to 0.5% (vol/vol) of halothane-82 Br vapour in oxygen for periods of time varying from 5 to 45 min. The chamber was fitted with a 1-inch plastic lid covered with aluminium foil to prevent the loss of halothane, which might otherwise penetrate the plastic. A small perforation in the lid allowed preliminary flushing of the chamber with 100% oxygen, administration of halothane and subsequent sampling as described below. The measured dose of liquid halothane containing 82 Br-labelled halothane in tracer amounts was injected on to a layer of glass wool (for rapid vaporization) supported upon a wire mesh suspended underneath the lid. Uniform distribution and constancy of concentration of halothane in the chamber were assured by mixing with a metal paddle and by gas chromatographic monitoring of samples of the vapour drawn from the chamber at intervals.
Preliminary experiments with non-radioactive halothane indicated that, during exposure of pregnant guineapigs to halothane vapour 0.5% in oxygen, for time periods of up to 45 min, the concentration of halothane remained constant, the concentration of oxygen did not fall below 20% and the concentration of carbon dioxide did not rise significantly (provided soda-lime (Baralyme) was spread on the floor of the chamber during exposures exceeding 30 min). The animals remained conscious and normally active throughout their exposure to halothane 0.5% in the chamber.
When halothane-82 Br was used, 2-ml samples of vapour were withdrawn from the chamber at intervals and their radioactive content measured by scintillation counting, using thallium-activated sodium iodide crystals. These counts were subsequently used to correct for variations in specific activity of the different batches of halothane-82 Br employed in individual experiments.
At the designated time, the guineapig was removed from the chamber, stunned, and immediately immersed in liquid nitrogen (temperature -196°C) for at least 20 min. This was intended to ensure complete freezing of all tissues and to reduce the vapour pressure of halothane to zero, thus minimizing both intertissue diffusion and actual loss of halothane from the carcass by diffusion and vaporization. The animal was then sectioned with a band saw and the slices kept frozen by re-immersion in liquid nitrogen. Tissue samples were obtained from the frozen slices by means of a cold chisel and a hammer. These were placed in preweighed and cooled 10-ml beakers which had been in contact with solid carbon dioxide (-78.5 °C) and surrounded by sponge rubber honeycomb for insulation. Three operators working simultaneously allowed sampling, counting and weighing to take place within 2 min during which time temperature changes and condensation of water vapour were minimal. The samples were immediately measured for radioactivity and subsequently weighed. The radioactivity measured in the tissues at this time was the total 82 Br present, either as halothane-' 2 Br or free 82 Br derived from halothane metabolism. A fourth operator was responsible for the final step which was separation of free 82 Br from the halothane-82 Br. This was achieved by extraction of free 82 Br by a modification of the method of Perlman, Morton and Chaikoff (1941) . Still frozen pieces of tissue were placed in 50-ml Erlenmeyer flasks containing silver nitrate 0.15M solution, 1 ml/g of tissue, and brought to boiling in less than 1 min to remove halothane vapour. Carrier sodium bromide was added, the flasks reboiled, and 1 ml of concentrated nitric acid added. The flasks were then placed in an incubator at 50° C for a minimum of 2 hours, following which the solution was filtered through a Buchner funnel with a perforated plate and two 4.25-cm Whatman 50 filter papers. A stainless steel cylinder of outside diameter 2.5 cm was held firmly in contact with the papers to limit the area of deposition of precipitate of silver bromide. Any material adhering to the wall of the cylinder was removed and pressed on to this area by means of a Teflon piston. The radioactivity on the paper was counted under standard conditions. (The filtrate was found to contain no radioactivity.)
In other studies in vitro, 5-g samples of maternal and foetal livers and brains obtained from pregnant guineapigs at term were homogenized with 3 ml of pH 7.4 phosphate buffer and 3 ml of normal saline. By means of a glass Y-delivery tube, halothane 5% in oxygen was bubbled simultaneously through maternal and foetal homogenates of each organ for 35 min. The halothane retained by each homogenate was then extracted by adding 10 ml of carbon tetrachloride and gently agitating and inverting for 5 min. A 3 /4 aliquot of the supernatant was injected into a Perkin-Elmer gas chromatograph for measurement of its halothane content.
RESULTS
(1) Guineapig tissues in vivo. Table I presents the numbers of counts from the samples of maternal and foetal tissues obtained at the times indicated. The counts were initially corrected for decay and for variations in specific activity of the 82 Br content of halothane inspired by the different guineapigs. The results obtained from duplicate and triplicate experiments at the varying time intervals were averaged. For each time of sampling, simple subtraction of the number of counts as free bromide (b) from the total (a) yielded the number attributable solely to labelled halothane
(c).
A downhill gradient in concentration of halothane-82 Br was demonstrated across the placenta between maternal and foetal (cardiac) blood in the 5-and 10-min sample; by 20 min the gradient had disappeared, indicating equilibration between the two blood streams. Despite the latter occurrence, halothane-82 Br concentrations in maternal brain were higher than those in foetal brain at all times of observation ( fig. 1) . Similarly, concentrations in maternal lung and kidney were consistently higher than in corresponding foetal tissues.
In sharp contrast to the findings in other tissues, the levels of radioactivity measured as halothane-82 Br in foetal liver after 5, 10 or 20 min of exposure of the mother to the vapour were slightly higher than those in maternal liver and 3-5 times greater after 30 and 45 min ( fig. 2) . At both of the latter times, the free 82 Br was also observed in greater amounts in the foetal livers.
(2) Guineapig tissues in vitro.
The results from duplicate estimations of halothane content of homogenates of foetal and maternal liver exposed to the vapour simultaneously measured by peak height on gas chromatography using a flame ionization detector, were 46 and 19 mm respectively, while the corresponding peak heights for foetal and maternal brain were 46 and 42 mm. The uptake of halothane by foetal liver in vitro was thus more than double that of maternal liver, whereas in maternal and foetal brain the uptake was almost identical.
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DISCUSSION
These findings with halothane-82 Br are consistent with other data obtained with thiopentone (Finster et al.j 1972a) and lignocaine (Finster et al., 1972b) . Each of these drugs has now been shown to pass freely across the placenta and into the foetal liver (except for the small fraction bypassing the liver via the ductus venosus) before gaining access to the rest of the foetus. At all times of observation with each drug, concentrations in the liver were higher in the foetus than in the mother. The foetal liver, situated at a strategic vascular crossroad, thus seems largely responsible for decreasing the amount of depressant or other drug reaching the foetal brain and other organs from the maternal circulation.
In the case of halothane-82 Br, large amounts of free "bromide were noted in the maternal and especially in the foetal livers at 30 and 45 min (table I  and fig. 2 ). These findings could result from the metabolic breakdown of halothane-82 Br by liver enzymes. Such a conclusion appears reasonable in the mother guineapig in whom concentrations of free
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Br at all times of observation were higher in the liver than in any other organ examined. However, the same explanation seems less likely in the foetus, since the relatively poor efficiency of this function of the liver in the perinatal period has been well documented with a variety of other drugs (Fouts and Hart, 1965) . It seems even less likely that the bromide ions liberated by halothane metabolism in the maternal liver would then be further concentrated in the foetal liver.
It is interesting to note that, in addition to its strategic location, exposing it to the first onslaught of drug which has crossed the placenta, the foetal liver also demonstrates a greater affinity for halothane than does the maternal liver (as indicated by the different uptake of halothane by homogenates of foetal and maternal guineapig liver exposed simultaneously to the same concentration of the vapour). On the other hand, since homogenates of foetal and maternal brain treated similarly exhibited almost identical uptake of halothane, the lower levels of halothane in foetal than in maternal brain could not be attributed to a lesser affinity of foetal brain for this agent.
Other phenomena contribute to the delayed uptake of halothane by the foetal brain. Unlike maternal tissues, which are in direct contact with maternal blood, foetal tissues (including the brain) are separated from maternal blood by another compartment, namely foetal blood (Adamsons, 1965) . Once in the foetal bloodstream, the halothane undergoes progressive dilution by admixture with foetal venous blood from the gastrointestinal tract, the lower extremities, the head and upper extremities, and even the lung. In addition, due to the extensive shunting via the foramen ovale and the ductus arteriosus, an estimated 57% of the combined cardiac output of the foetal lamb (and presumably a comaparable amount in the guineapig) returns to the placenta without perfusing foetal tissues (Dawes, Mott and Widdicombe, 1954) . All of these factors together with the large hepatic uptake, contribute to the lesser accumulation of halothane demonstrated in foetal tissues as compared to the corresponding tissues in the mother.
The pharmacokinetics of halothane in the mother and in the foetus differ importantly from those of thiopentone and lignocaine, due to differences in their method of administration. In contrast to the other two agents, which are usually given by single or intermittent injections, halothane is, of course, administered by inhalation, a process which was maintained throughout the period of observation in these experiments. In consequence, blood and tissue time-concentration curves for halothane show a generally rising course, in contrast to the falling course encountered with thiopentone and lignocaine. Although drug concentrations in foetal brain and other important tissues remain persistently below those in maternal tissues, pharmacologically effective concentrations in the brain and elsewhere in the foetus will ultimately be achieved, given sufficient duration and dosage of drug administered to the mother. This danger is heightened by the fact that newborns are more sensitive to the actions of depressant drugs than are adults of the same species (Moya and Thorndike, 1963) .
DISTRIBUCION DEL HALOTANO -^Br EN LOS TEJIDOS MATERNOS Y FETALES DE COBAYAS

RESUMEN
La distribuci6n de halotano-^r en los tejidos maternos y fetales fue estudiada en cobayas gestantes proximas al termino expuestas a una concentration al 0,5 por ciento del vapor durante periodos de 5 hasta 45 minutos. La actividad especifica del marcador ^Br, observada todas las veces, era mas elevada en el cerebro, pulmon y ririon maternos que en los correspondientes tejidos fetales. Por el contrario, la actividad especifica era ligeramente mas elevada en el higado fetal que en el materno hasta los 20 minutos y mas de tres veces mayor a los 30 y 45 minutos. La retention de halotano por el higado fetal "in vitro" era mas del doble que la del higado materno; la retenci6n en el cerebro materno y fetal fue identica. El higado fetal juega un papel importante en la disminucion de la cantidad de halotano que llega al cerebro fetal desde la circulation materna.
ASSOCIATION OF ANAESTHETISTS OF GREAT BRITAIN AND IRELAND
Research and Education Grants
The Research and Education Committee of the Association of Anaesthetists will consider applications from Members needing financial assistance for educational or research purposes. The award of grants falls into two main categories: 1. For research projects carried out by an individual working under supervision, or for a specific piece of research as part of a Departmental project. Grants of more than £1000 (towards salary or equipment) are unlikely to be exceeded, except in special circumstances. 2. For travel grants towards the expenses of a tour abroad which includes either teaching, learning, or research. Grants will not be made for the purpose of taking up a post abroad, but may be made for extending the candidate's travel within the terms already stated. Grants in the region of £100-£150 may be given.
CRITERIA IN MAKING AWARDS
In considering applications, the Committee will bear the following in mind: 1.
Research Projects
The amount of local support promised. Where salaries or large sums are involved, the amount of support likely to be given by the Medical Research Council, the Wellcome Foundation, etc. The suitability of the project, and the effectiveness of a contribution from the Association.
Travel Grants
The purpose of the proposed visit abroad. The suitability of the itinerary in regard to the purpose. Contributions, if any, from other organizations or the applicant's employing authority.
Value of emoluments to be received during the visit, including salary.
WHERE AND HOW TO APPLY
Travel grants: Application form obtainable on application to the Hon. Secretary, Association of Anaesthetists, Room 126, Tavistock House North, Tavistock Square, London WC 1H 9HR.
Research grants: No set form is supplied. Applicants are asked to submit full details of the proposed project, outlining the facilities available, any pilot schemes already made, and detailed costing of the items requested.
CLOSING DATES
End of October for research projects. Any time for travel grants. FOLLOW-UP REPORTS will be asked for, and published in the Association's Annual Report.
